CA
BVS icon

Cetera Advisors’s Bioventus BVS Stock Holding History

Cetera Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,391
Closed -$47.4K – 1721
2023
Q2 		$47.4K Sell
16,391
-5,077
-24% -$9.74K ﹤0.01% 1606
2023
Q1 		$23K Buy
21,468
+1,832
+9% +$3.5K ﹤0.01% 1620
2022
Q4 		$51.3K Buy
+19,636
New +$85.7K ﹤0.01% 1545

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cetera Advisors's BVS Position: Q3 2023 in Review

Cetera Advisors sold out of Bioventus (BVS) in Q3 2023, closing a stake of 16,391 shares — an estimated $47.4K sold.

Cetera Advisors first reported a position in BVS in Q4 2022 and held it in 3 quarters. The position peaked at $51.3K in Q4 2022. 67 funds tracked by Wall St. Rank hold BVS as of Q3 2023.

  • Cetera Advisors reported no remaining Bioventus position as of Q3 2023 after selling out during the quarter.
  • Cetera Advisors sold 16,391 Bioventus shares in Q3 2023, an estimated $47.4K.
  • Cetera Advisors first reported a position in Bioventus in Q4 2022 and held it in 3 quarters.
  • Cetera Advisors's Bioventus position peaked at $51.3K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held Bioventus as of Q3 2023.

Based on Cetera Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.